“Computational Analysis of FDA-Approved Drugs for Potential Repurposing in Alzheimer’s Disease: Targeting MTOR and NGFR Pathways”. Science Essence Journal 42, no. 1 (January 5, 2026): 50–70. Accessed October 23, 2026. https://ejournals.swu.ac.th/sej/article/view/17130.